Amarin Corp Plc (AMRN)

[Tatsumaki]

Dr's prescribed L for CVD benefit before V even existed. It was the whole point and marketing of the drug. Lower Tg used to mean CVD benefit before FDA ended it as a viable biomarker. L didnt sell billions curing pancreatitis. Sure infringement is taking place, but GL's existence and current Rx levels fully insulate GV sellers from any risk. No court will side with Amarin claiming infringement on sales volumes alone trying to define a legitimate market size.